| Literature DB >> 24023910 |
Hua Zhang1, Chao Fei, Haizhen Wu, Minjun Yang, Qin Liu, Qiyao Wang, Yuanxing Zhang.
Abstract
BACKGROUND: A candidate vaccine, live attenuated Vibrio anguillarum developed in our laboratory could prevent vibriosis of fish resulted from V. anguillarum and V. alginolyticus. To elucidate the molecular mechanisms underlying the vaccine protection, we used microarray technology to compare the spleen transcriptomes of bath-vaccinated and unvaccinated zebrafish at 28 days post vaccination. PRINCIPALEntities:
Mesh:
Substances:
Year: 2013 PMID: 24023910 PMCID: PMC3762715 DOI: 10.1371/journal.pone.0073871
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
GO function annotation results of differentially expressed genes.
| Term | GO ID | Description | Gene No. | % |
|
| BP_2 | GO:0044237 | Cellular metabolic process | 292 | 20.3 | 0.0000 |
| BP_2 | GO:0009058 | Biosynthetic process | 140 | 9.7 | 0.0015 |
| BP_2 | GO:0006807 | Nitrogen compound metabolic process | 138 | 9.6 | 0.0035 |
| BP_2 | GO:0048522 | Positive regulation of cellular process | 25 | 1.7 | 0.0114 |
| BP_2 | GO:0048518 | Positive regulation of biological process | 26 | 1.8 | 0.0139 |
| BP_2 | GO:0055085 | Transmembrane transport | 44 | 3.1 | 0.0141 |
| BP_2 | GO:0009893 | Positive regulation of metabolic process | 13 | 0.9 | 0.0148 |
| BP_2 | GO:0009056 | Catabolic process | 46 | 3.2 | 0.0198 |
| BP_2 | GO:0006996 | Organelle organization | 39 | 2.7 | 0.0328 |
| BP_2 | GO:0043170 | Macromolecule metabolic process | 237 | 16.5 | 0.0390 |
| BP_2 | GO:0042440 | Pigment metabolic process | 5 | 0.3 | 0.0520 |
| BP_2 | GO:0044238 | Primary metabolic process | 293 | 20.4 | 0.0524 |
| BP_2 | GO:0043933 | Macromolecular complex subunit organization | 18 | 1.2 | 0.0724 |
| BP_2 | GO:0048523 | Negative regulation of cellular process | 21 | 1.5 | 0.0859 |
| BP_2 | GO:0006950 | Response to stress | 36 | 2.5 | 0.0889 |
| BP_2 | GO:0007163 | Establishment or maintenance of cell polarity | 4 | 0.3 | 0.0980 |
| MF_2 | GO:0000166 | Nucleotide binding | 166 | 11.6 | 0.0016 |
| MF_2 | GO:0016563 | Transcription activator activity | 11 | 0.8 | 0.0046 |
| MF_2 | GO:0003676 | Nucleic acid binding | 198 | 13.8 | 0.0089 |
| MF_2 | GO:0008135 | Translation factor activity | 14 | 1.0 | 0.0160 |
| MF_2 | GO:0001882 | Nucleoside binding | 104 | 7.2 | 0.0330 |
| MF_2 | GO:0048037 | Cofactor binding | 24 | 1.7 | 0.0390 |
| MF_2 | GO:0016874 | Ligase activity | 26 | 1.8 | 0.0560 |
| MF_2 | GO:0008289 | Lipid binding | 21 | 1.5 | 0.0580 |
| CC_2 | GO:0044424 | Intracellular part | 323 | 22.5 | 0.0015 |
| CC_2 | GO:0005622 | Intracellular | 395 | 27.55 | 0.0016 |
| CC_2 | GO:0031967 | Organelle envelope | 25 | 1.75 | 0.0182 |
| CC_2 | GO:0043227 | Membrane-bounded organelle | 223 | 15.55 | 0.0429 |
| CC_2 | GO:0043233 | Organelle lumen | 25 | 1.75 | 0.0525 |
| CC_2 | GO:0043229 | Intracellular organelle | 257 | 17.9 | 0.0686 |
| CC_2 | GO:0044422 | Organelle part | 87 | 6.0 | 0.0816 |
| CC_2 | GO:0044446 | Intracellular organelle part | 87 | 6.0 | 0.0816 |
the percentage of genes in the specific subcategory from each of the three GO ontologies.
Top 20 of Statistically significant KEGG pathways in response to vaccination.
| Category | Gene No. |
| FDR |
| Ribosome | 20 | 0.0000 | 0.0000 |
| Metabolic pathways | 84 | 0.0000 | 0.0000 |
| MAPK signaling pathway | 31 | 0.0000 | 0.0000 |
| Spliceosome | 18 | 0.0000 | 0.0000 |
| Protein processing inendoplasmic reticulum | 21 | 0.0000 | 0.0000 |
| RNA transport | 18 | 0.0000 | 0.0003 |
| Insulin signaling pathway | 18 | 0.0000 | 0.0006 |
| Hedgehog signaling pathway | 10 | 0.0001 | 0.0016 |
| Phenylalanine metabolism | 5 | 0.0002 | 0.0026 |
| Dorso-ventral axis formation | 6 | 0.0004 | 0.0054 |
| Wnt signaling pathway | 17 | 0.0004 | 0.0054 |
| Pyrimidine metabolism | 12 | 0.0004 | 0.0054 |
| Regulation of actin cytoskeleton | 20 | 0.0010 | 0.0109 |
| Melanogenesis | 13 | 0.0010 | 0.0109 |
| Protein export | 5 | 0.0013 | 0.0134 |
| Cytokine-cytokinereceptor interaction | 14 | 0.0018 | 0.0159 |
| Endocytosis | 20 | 0.0018 | 0.0159 |
| Tight junction | 14 | 0.0019 | 0.0159 |
| Purine metabolism | 15 | 0.0021 | 0.0167 |
| RIG-I-like receptorsignaling pathway | 7 | 0.0044 | 0.0336 |
Figure 1Validation of relative expression between microarray data and RT-qPCR results at 28 days post vaccination.
iNOS2a: inducible nitric oxide synthase 2, itga3b: integrin alpha 3b, STAT5: Signal Transducer and Activator of Transcription 5, IL7R: interleukin 7 receptor, IL22: interleukine 22, Bcl6ab: B-cell CLL/lymphoma 6a, Cdc42l: cell division cycle 42 like, Mycb: myelocytomatosis oncogene b, ABCB8: ATP-binding cassette sub-family B member 8, Cts1a: cathepsin L 1 a.
List of differentially expressed genes related to innate immunity.
| Accession Number | Gene Name |
| Fold | Description |
|
| ||||
| XM_002662721 | LTB4R | 0.0057 | 9.19 | Leukotriene B4 receptor 1-like |
| NM_001104937 | iNOS2a | 0.0310 | 7.50 | Nitric oxide synthase 2a, inducible |
| XR_084418.2 | MRC1 | 0.0004 | 6.33 | Mannose receptor C type 1-like (LOC100329625) |
| NM_201503 | MMP13a | 0.0481 | 6.12 | Matrix metalloproteinase 13a |
| XM_683237 | Prf1 | 0.0088 | 5.69 | Novel protein similar to mouse and rat perforin 1 (Pore forming protein) (Prf1) Fragment |
| NM_205554 | atp6v0cb | 0.0109 | 2.33 | ATPase, H+ transporting, lysosomal, V0 subunit c, b |
| NM_173255 | atp6v0ca | 0.0248 | 2.27 | ATPase, H+ transporting, lysosomal, V0 subunit c, a |
| NM_213123 | MMP9 | 0.0192 | 2.05 | Matrix metalloproteinase 9 |
| NM_199865 | Cdc42l | 0.0206 | 1.66 | Cell division cycle 42, like |
| NM_205554 | atp6v0cb | 0.0078 | 1.62 | ATPase, H+ transporting, lysosomal, V0 subunit c, b |
|
| ||||
| NM_001017734 | Steap4 | 0.0156 | 3.10 | STEAP family member 4 |
| NM_001128234 | SLC30a10 | 0.0365 | 2.75 | Solute carrier family 30 (zinc transporter), member 10 |
| BC092881 | ISCU | 0.0303 | 2.45 | Iron-sulfur cluster scaffold homolog |
| NM_001103139 | Hmox2a | 0.0445 | 2.32 | Heme oxygenase (decycling) 2 |
| NM_001076602 | SLC25a38a | 0.0370 | 2.27 | Solute carrier family 25, member 38 |
| NM_001040370 | SLC11a2 | 0.0007 | 2.22 | Solute carrier family 11 (proton-coupled divalent metal iron transporters),member 2 |
| NM_200486 | SLC25a39 | 0.0350 | 2.02 | Solute carrier family 25, member 39 |
| NM_201192 | PCBP2 | 0.0212 | 1.91 | Poly(rC) binding protein 2 |
| XM_001341755 | IREB2 | 0.0009 | 1.64 | Iron-responsive element binding protein 2 |
| NM_001017544 | ABCB8 | 0.0059 | −3.09 | ATP-binding cassette, sub-family B (MDR/TAP), member 8 |
| NM_199659 | cul1a | 0.0387 | −4.77 | cullin 1a |
| NM_001076601 | Blvra | 0.0460 | −6.08 | Biliverdinreductase A |
| NM_001076662 | SFXN4 | 0.0030 | −8.34 | Sideroflexin 4 |
| NM_001045438 | TMEM14c | 0.0039 | −10.68 | Transmembrane protein 14C |
| NM_213021 | Glrx5 | 0.0204 | −11.97 | Glutaredoxin 5 homolog ( |
| BC107969 | TfR2 | 0.0051 | −12.93 | Transferrin receptor 2 |
| NM_201306 | LRPAP1 | 0.0141 | −13.79 | Low density lipoprotein receptor-related protein associated protein 1 |
Figure 2Iron uptake and metabolism were enhanced in the bath-vaccinated zebrafish.
Genes related to putative iron metabolism of intracellular iron and competition for extracellular iron were differentially modulated after vaccination with the live attenuated V. anguillarum. Red: up-regulated, Green: down-regulated, Black: not found to be modulated.
List of differentially expressed genes related to adaptive immunity.
| Accession number | Gene name |
| Fold | Description | |
|
| |||||
| NM_001043334 | EpoR | 0.0025 | 9.24 | Erythropoietin receptor, involved with erythroidand lymphoid differentiation | |
| NM_001113595 | CCL20 | 0.0119 | 3.27 | Chemokine (C-C motif) ligand 20 | |
| BC083364 | XCR1a | 0.0043 | 3.16 | Chemokine (C motif) receptor 1 | |
| NM_001037683 | TGFBR1a | 0.0367 | 3.12 | Transforming growth factor, beta receptor 1 a | |
| BC098597 | IL1β | 0.0395 | 2.62 | Interleukin 1, beta | |
| NM_194386 | TGFb3 | 0.0326 | 2.52 | Transforming growth factor, beta 3 | |
| NM_001083868 | crfb4 | 0.0098 | 2.35 | Cytokine receptor family member b4 | |
| NM_001113507 | IL7R | 0.0109 | 2.24 | Interleukin 7 receptor | |
| BC163192 | IL22 | 0.0228 | 2.08 | Interleukin 22 | |
| NM_207640 | ifnphi1 | 0.0467 | 1.94 | Interferon phi 1 (IFNΦ), mRNA | |
| NM_205762 | traf4a | 0.0449 | 1.58 | TNF receptor-associated factor 4a | |
| NM_001113625 | trap1 | 0.0165 | 1.55 | TNF receptor-associated protein 1 | |
|
| |||||
| AF246168 | TCRAV | 0.0061 | 5.96 | Isolate G5209 T-cell receptor alpha variable region mRNA, partial cds. | |
| NM_001190309 | itga3b | 0.0181 | 4.44 | Integrin, alpha 3b | |
| NM_212634 | alcamb | 0.0073 | 3.38 | Activated leukocyte cell adhesion molecule b | |
| XM_002666544 | Nfxl1 | 0.0003 | 3.32 | Nuclear transcription factor, X-box binding-like 1 (Named Xbp1 in human) | |
| XM_001923447 | CD28 | 0.0236 | 3.23 | T-cell-specific surface glycoprotein CD28-like (LOC100151365) | |
| NM_194387 | STAT5.1 | 0.0112 | 3.20 | Signal transducer and activator of transcription 5.1 | |
| DN898368 | itgb7 | 0.0016 | 3.13 | Integrin, beta 7 | |
| NM_001040369 | tnfrsf9a | 0.0465 | 3.13 | TNF receptor superfamily, member 9a | |
| AY841759 | Prdm1a | 0.0248 | 3.07 | PR domain containing 1a, with ZNF domain (homolog to Blimp of human) | |
| NM_001082997 | CD40 | 0.0037 | 2.57 | CD40 molecule, TNF receptor superfamily member 5 | |
| NM_198878 | rbpja | 0.0033 | 2.47 | Recombination signal binding protein for immunoglobulin kappa J region a | |
| NM_200909 | creb1a | 0.0042 | 2.31 | cAMP responsive element binding protein 1a | |
| NM_001007167 | MHC II | 0.0483 | 1.88 | Major histocompatibility complex class II (MHC II) DAB gene | |
| NM_200366 | STAT6 | 0.0162 | 1.87 | signal transducer and activator of transcription 6, interleukin-4 induced | |
| NM_001100074 | Bcl6ab | 0.0287 | 1.86 | B-cell CLL/lymphoma 6a, genome duplicate b (similar to Bcl-6 of human) | |
| NM_001110403 | hspa8 | 0.0149 | 1.81 | Heat shock protein 8 | |
| NM_001080622 | CD276 | 0.0421 | 1.75 | CD276 molecule | |
| NM_214716 | hspa4a | 0.0492 | 1.70 | Heat shock protein 4a | |
| NM_200172 | Mycb | 0.0217 | −1.88 | Myelocytomatosis oncogene b | |
| NM_131198 | Ctsl1b | 0.0120 | −2.05 | Cathepsin L b, hatching gland gene 1 | |
| NM_001045076 | hspa14 | 0.0310 | −2.07 | Heat shock protein 14 | |
| NM_001089476 | hsf5 | 0.0168 | −2.06 | Heat shock transcription factor family member 5 | |
| BC090693 | FNYBb | 0.0455 | −2.38 | Nuclear transcription factor Y, beta b | |
| BC063995 | mhc1ze | 0.0477 | −3.25 | Major histocompatibility complex class I ZE gene | |
| NM_212584 | Ctsl1a | 0.0435 | −3.80 | Cathepsin L 1a | |
| NM_200075 | hspbp1 | 0.0307 | −4.90 | HSPA (heat shock 70 kDa) binding protein, cytoplasmic cochaperone 1 | |
| NM_213522 | igbp1 | 0.0051 | −4.95 | Immunoglobulin (CD79A) binding protein 1 | |
| XM_001343036 | Ciita | 0.0413 | −5.61 | Class II, major histocompatibility complex, transactivator | |
| NM_198210 | hsp90b1 | 0.0277 | −8.64 | Heat shock protein 90, beta (grp94), member 1 | |
Figure 3Putative differentiation pathway of Th17 cells in zebrafish.
The genes related to Th17 cells differentiation and proliferation were modulated after vaccination with the live attenuated V. anguillarum. Red: up-regulated, Black: not found to be modulated.
Figure 4Temporal expression profiling of Th17-related genes and integrin β7 during 35 days post bath-vaccination.
The mRNA level of each gene was normalized to that of β-actin. Each bar represents the mean of three biological replicates (3 pools) and error bars represent standard deviation. (* p<0.05).
Figure 5Effects of vaccination with the live attenuated V. anguillarum on Wnt signaling pathway.
The genes related to Wnt signaling pathway were modulated after vaccination with the live attenuated V. anguillarum. Red: up-regulated, Green: down-regulated, Black: not found to be modulated. WNT: wingless-type MMTV integration site family, DKK1: Dickkopf homologue 1, LRP5/6: LDL-receptor-related protein 5/6, CK1: casein kinase, GSK3β: glycogen synthase kinase 3β, AXIN: axis inhibition protein, DVL: mammalian homologue of Drosophila dishevelled, APC : adenomatous polyposis coli, PKA: cAMP-dependent protein kinase catalytic subunit alpha, PS-1: presenilin 1, PYGO: legless CREB binding protein, LGS: pygopus CREB binding protein, TCF: T-cell factor, GRG:Groucho, CTBP: C-terminal binding protein, HDAC: histone deacetylases, STBM: VANGL planar cell polarity protein 2, DAAM: dishevelled associated activator of morphogenesis, RHOA: ras homolog family member A, RAC: ras-related C3 botulinum toxin substrate, ROCK: Rho-associated coiled-coil containing protein kinase, JNK: Jun N-terminal kinase, JUN: jun proto-oncogene, PLC: phospholipase C, PKC: protein kinase C, CAMKII: calcium calmodulin mediated kinase II, NFAT: nuclear factor of activated T cells.